European Union - English - EMA (European Medicines Agency)

meda ab - zaleplon - sleep initiation and maintenance disorders - psycholeptics - zerene is indicated for the treatment of patients with insomnia who have difficulty falling asleep. it is indicated only when the disorder is severe, disabling or subjecting the individual to extreme distress.

Canada - English - Health Canada

pfizer canada ulc - zaleplon - capsule - 5mg - zaleplon 5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

pfizer canada ulc - zaleplon - capsule - 10mg - zaleplon 10mg - miscellaneous anxiolytics sedatives and hypnotics

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - zaleplon -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - zaleplon -

Canada - English - Health Canada

servier canada inc - zaleplon - capsule - 5mg - zaleplon 5mg - miscellaneous anxiolytics sedatives and hypnotics

Canada - English - Health Canada

servier canada inc - zaleplon - capsule - 10mg - zaleplon 10mg - miscellaneous anxiolytics sedatives and hypnotics

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - zaleplon 10mg - capsule - 10 mg - active: zaleplon 10mg excipient: gelatin hydrated silica lactose monohydrate magnesium stearate powdered cellulose sodium laurilsulfate starch

New Zealand - English - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - zaleplon 5mg - capsule - 5 mg - active: zaleplon 5mg excipient: gelatin hydrated silica lactose monohydrate magnesium stearate powdered cellulose sodium laurilsulfate starch

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - zaleplone - capsule - 10 mg